155 related articles for article (PubMed ID: 28799801)
41. Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1.
Arnault JP; Mateus C; Escudier B; Tomasic G; Wechsler J; Hollville E; Soria JC; Malka D; Sarasin A; Larcher M; André J; Kamsu-Kom N; Boussemart L; Lacroix L; Spatz A; Eggermont AM; Druillennec S; Vagner S; Eychène A; Dumaz N; Robert C
Clin Cancer Res; 2012 Jan; 18(1):263-72. PubMed ID: 22096025
[TBL] [Abstract][Full Text] [Related]
42. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
43. Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence.
Zhang H; Herman AI; Kranzler HR; Anton RF; Simen AA; Gelernter J
J Hum Genet; 2012 Oct; 57(10):670-5. PubMed ID: 22914673
[TBL] [Abstract][Full Text] [Related]
44. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS
J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502
[TBL] [Abstract][Full Text] [Related]
45. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
46. Validation of differential GDAP1 DNA methylation in alcohol dependence and its potential function as a biomarker for disease severity and therapy outcome.
Brückmann C; Di Santo A; Karle KN; Batra A; Nieratschker V
Epigenetics; 2016 Jun; 11(6):456-63. PubMed ID: 27128683
[TBL] [Abstract][Full Text] [Related]
47. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer.
Tan C; Xu HY; Zhang CY; Zhang H; Chen CM; Zhang WM; Sun XY; Jin YT
Arch Med Res; 2011 Nov; 42(8):669-76. PubMed ID: 22154617
[TBL] [Abstract][Full Text] [Related]
48. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
49. DAT1 methylation changes in alcohol-dependent individuals vs. controls.
Jasiewicz A; Rubiś B; Samochowiec J; Małecka I; Suchanecka A; Jabłoński M; Grzywacz A
J Psychiatr Res; 2015 May; 64():130-3. PubMed ID: 25862379
[TBL] [Abstract][Full Text] [Related]
50. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J
Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111
[TBL] [Abstract][Full Text] [Related]
51. Epigenetic modifications, chromatin distribution and TP53 transcription in a model of breast cancer progression.
Santos GC; da Silva AP; Feldman L; Ventura GM; Vassetzky Y; de Moura Gallo CV
J Cell Biochem; 2015 Apr; 116(4):533-41. PubMed ID: 25358520
[TBL] [Abstract][Full Text] [Related]
52. Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis.
Miyakura Y; Sugano K; Konishi F; Fukayama N; Igarashi S; Kotake K; Matsui T; Koyama Y; Maekawa M; Nagai H
Genes Chromosomes Cancer; 2003 Jan; 36(1):17-25. PubMed ID: 12461746
[TBL] [Abstract][Full Text] [Related]
53. Comparison of effects of p53 null and gain-of-function mutations on salivary tumors in MMTV-Hras transgenic mice.
Jiang D; Dumur CI; Massey HD; Ramakrishnan V; Subler MA; Windle JJ
PLoS One; 2015; 10(2):e0118029. PubMed ID: 25695772
[TBL] [Abstract][Full Text] [Related]
54. DNA methylation of the POMC gene promoter is associated with craving in alcohol dependence.
Muschler MA; Hillemacher T; Kraus C; Kornhuber J; Bleich S; Frieling H
J Neural Transm (Vienna); 2010 Apr; 117(4):513-9. PubMed ID: 20191296
[TBL] [Abstract][Full Text] [Related]
55. Methylation in the TP53 promoter is associated with ischemic stroke.
Wei Y; Sun Z; Wang Y; Xie Z; Xu S; Xu Y; Zhou X; Bi J; Zhu Z
Mol Med Rep; 2019 Aug; 20(2):1404-1410. PubMed ID: 31173230
[TBL] [Abstract][Full Text] [Related]
56. DNA methylation signatures: Biomarkers of drug and alcohol abuse.
Mahna D; Puri S; Sharma S
Mutat Res Rev Mutat Res; 2018; 777():19-28. PubMed ID: 30115428
[TBL] [Abstract][Full Text] [Related]
57. DNA methylation age is accelerated in alcohol dependence.
Rosen AD; Robertson KD; Hlady RA; Muench C; Lee J; Philibert R; Horvath S; Kaminsky ZA; Lohoff FW
Transl Psychiatry; 2018 Sep; 8(1):182. PubMed ID: 30185790
[TBL] [Abstract][Full Text] [Related]
58. DNA hypermethylation of the alpha synuclein promoter in patients with alcoholism.
Bönsch D; Lenz B; Kornhuber J; Bleich S
Neuroreport; 2005 Feb; 16(2):167-70. PubMed ID: 15671870
[TBL] [Abstract][Full Text] [Related]
59. An Integrated Global Analysis of Compartmentalized HRAS Signaling.
Santra T; Herrero A; Rodriguez J; von Kriegsheim A; Iglesias-Martinez LF; Schwarzl T; Higgins D; Aye TT; Heck AJR; Calvo F; Agudo-Ibáñez L; Crespo P; Matallanas D; Kolch W
Cell Rep; 2019 Mar; 26(11):3100-3115.e7. PubMed ID: 30865897
[TBL] [Abstract][Full Text] [Related]
60. Global DNA promoter methylation in frontal cortex of alcoholics and controls.
Manzardo AM; Henkhaus RS; Butler MG
Gene; 2012 Apr; 498(1):5-12. PubMed ID: 22353363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
